One cyber incident can halt production, disrupt distribution and compromise patient safety. The Cencora breach in 2024 exposed an intimidating truth: pharmaceutical supply chains are among the most vulnerable to cyberattacks. It highlights why the future of pharma logistics depends not only on efficiency, but also on resilience.
This sensitive topic lies at the core of Session 4 – Smart Supply Chains: Transformation of Pharma Logistics, at AUTOMA+ 2025. The discussion explores innovations reshaping the supply chain, from real-world AI applications and predictive analytics to blockchain and digital twins.
Key insights include:
- Philipp Nobel (Kardex Holding AG): Strategies for smarter handling of healthcare supplies;
- Cédric Colon (GSK): Driving value through digitalisation and AI;
- Martin Riester (Fraunhofer Austria): Applying AI and Data Science to boost resilience, efficiency and agility;
- Weslley Mota (Director, Strategic Business Integration at Bristol Myers Squibb) – Change Readiness & the People-Centric Side of Transformation.
Ultimately, digital innovation emerges as the most effective defence against systemic disruptions, enabling companies to secure operations while optimising performance from the laboratory to the warehouse.
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025 takes place on 24–25 September in Vösendorf, Austria. It brings together industry leaders to address not only logistics and cybersecurity challenges but also critical topics in packaging, R&D, laboratory systems, production processes and many others. The Congress is a place where the decision-makers from the leading pharmaceutical companies and the technology providers meet to find sufficient solutions for industry development.
